Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 528 participants.

Also called NCT01968577

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 528 participants (planned count) (from the registry)
Sponsor
Kleber Bomfim Araujo Martins (from the registry)
Registry
  • NCT NCT01968577
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01968577. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention
Acronym
CLEAR-PCI
Intervention (Drug)
Rosuvastatin
Lead sponsor
Kleber Bomfim Araujo Martins (class: other)

Record details

Record id
cardio:ct-nct01968577
Content hash
23d597f8934c094ea6a9040238ccb9e8ac2961782b2928a4b731a562c6e56bc2